140 related articles for article (PubMed ID: 20577835)
1. CD4-positive diffuse large B cell lymphoma identified by flow cytometry: two case reports.
Arrondini M; Barreca A; Aliberti S; Demurtas A; Tondat F; Novero D; Stacchini A
Int J Hematol; 2010 Jul; 92(1):198-203. PubMed ID: 20577835
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.
Kaleem Z; White G; Zutter MM
Am J Clin Pathol; 2001 Mar; 115(3):396-403. PubMed ID: 11242796
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma with aberrant expression of the T-cell antigens CD2 and CD7.
Sangle NA; Agarwal AM; Smock KJ; Leavitt MO; Warnke R; Bahler D; Perkins SL
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):579-83. PubMed ID: 21836500
[TBL] [Abstract][Full Text] [Related]
5. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+ B cells in diffuse large B cell lymphoma.
Zhou Y; Zha J; Lin Z; Fang Z; Zeng H; Zhao J; Luo Y; Li Z; Xu B
Exp Cell Res; 2018 Jan; 362(2):287-292. PubMed ID: 29174982
[TBL] [Abstract][Full Text] [Related]
7. De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology.
Cioc AM; Jessurun J; Vercellotti GM; Pambuccian SE
Diagn Cytopathol; 2014 Mar; 42(3):259-67. PubMed ID: 23007953
[TBL] [Abstract][Full Text] [Related]
8. CD3-positive large B-cell lymphoma.
Wang J; Chen C; Lau S; Raghavan RI; Rowsell EH; Said J; Weiss LM; Huang Q
Am J Surg Pathol; 2009 Apr; 33(4):505-12. PubMed ID: 19011566
[TBL] [Abstract][Full Text] [Related]
9. [Application of flow cytometry in diagnosis of T-cell rich diffuse large B-cell lymphoma].
Xia CQ; Qi M; Xu XF; Li LH; Zhao HY
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):29-32. PubMed ID: 17374235
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of multiple T antigens: CD4, CD5, and CD8 on diffuse large B-cell lymphoma.
Sangle NA; Miles RR; Kelley TW; Perkins SL
Appl Immunohistochem Mol Morphol; 2014; 22(10):e45-8. PubMed ID: 24185124
[TBL] [Abstract][Full Text] [Related]
11. CD4-positive diffuse large B-cell lymphoma: A variant with aggressive clinical potential.
Hussaini MO; Kreisel FH; Hassan A; Nguyen TT; Frater JL
World J Methodol; 2016 Sep; 6(3):181-6. PubMed ID: 27679780
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
Knowles DM
Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
[TBL] [Abstract][Full Text] [Related]
14. Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells.
Suzuki Y; Yoshida T; Wang G; Aoki T; Katayama T; Miyamoto S; Miyazaki K; Iwabuchi K; Danbara M; Nakayama M; Horie R; Nakamine H; Sato Y; Nakamura N; Niitsu N
Acta Haematol; 2013; 130(4):230-7. PubMed ID: 23816831
[TBL] [Abstract][Full Text] [Related]
15. Unilateral uveitis masquerade syndrome caused by diffuse large B-cell lymphoma diagnosed using multiparametric flow cytometry of the aqueous humor.
Monsalvo S; Serrano C; Prieto E; Fernández-Sanz G; Puente MC; Rodriguez-Pinilla M; Garcia Raso A; Llamas P; Cordoba R
Cytometry B Clin Cytom; 2017 Jul; 92(4):286-290. PubMed ID: 26860883
[TBL] [Abstract][Full Text] [Related]
16. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
[TBL] [Abstract][Full Text] [Related]
17. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.
Quintanilla-Martinez L; Preffer F; Rubin D; Ferry JA; Harris NL
Am J Clin Pathol; 1994 Oct; 102(4):483-9. PubMed ID: 7524302
[TBL] [Abstract][Full Text] [Related]
18. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
[TBL] [Abstract][Full Text] [Related]
19. CD5- and CD23-positive splenic diffuse large B-cell lymphoma with very low CD20 expression.
Tabata R; Iwama H; Tabata C; Yasumizu R; Kojima M
J Clin Exp Hematop; 2014; 54(2):155-61. PubMed ID: 25318949
[TBL] [Abstract][Full Text] [Related]
20. Use of immune repertoire sequencing to resolve discordant microscopic and immunochemical findings in a case of T cell-rich large B cell lymphoma in a young dog.
Lee GKC; Bienzle D; Keller SM; Hwang MH; Darzentas N; Chang H; Rätsep E; Egan R; Beeler-Marfisi J
BMC Vet Res; 2021 Feb; 17(1):85. PubMed ID: 33602231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
